{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T23:56:02Z","timestamp":1786578962038,"version":"build-2736575974"},"reference-count":48,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2007,4,10]],"date-time":"2007-04-10T00:00:00Z","timestamp":1176163200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2007,8]]},"abstract":"<jats:sec><jats:label\/><jats:p><jats:bold>What is already known about this subject<\/jats:bold><\/jats:p><jats:p>\u2022\u2002Flavonoids are largely recognized as potential inhibitors of platelet function, through nonspecific mechanisms such as antioxidant activity and\/or inhibition of several enzymes and signalling proteins.<\/jats:p><jats:p>\u2022\u2002In addition, we, and few others, have shown that certain antiaggregant flavonoids may behave as specific TXA2 receptor (TP) ligands in platelets.<\/jats:p><jats:p>\u2022\u2002Whether flavonoids interact with TP isoforms in other cell types is not known, and direct evidence that flavonoid\u2013TP interaction inhibits signalling downstream TP has not been shown.<\/jats:p><jats:p><jats:bold>What this study adds<\/jats:bold><\/jats:p><jats:p>\u2022\u2002This study first demonstrates that certain flavonoids behave as ligands for both TP isoforms, not only in platelets, but also in human myometrium and in TP\u2010transfected HEK 293T cells.<\/jats:p><jats:p>\u2022\u2002Differences in the effect of certain flavonoids in platelet signalling, induced by either U46619 or thrombin, suggest that abrogation of downstream TP signalling is related to their specific blockage of the TP, rather than to a nonspecific effect on tyrosine kinases or other signalling proteins.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aims<\/jats:title><jats:p>Flavonoids may affect platelet function by several mechanisms, including antagonism of TxA<jats:sub>2<\/jats:sub>receptors (TP). These TP are present in many tissues and modulate different signalling cascades. We explored whether flavonoids affect platelet TP signalling, and if they bind to TP expressed in other cell types.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Platelets were treated with flavonoids, or other selected inhibitors, and then stimulated with U46619. Similar assays were performed in aspirinized platelets activated with thrombin. Effects on calcium release were analysed by fluorometry and changes in whole protein tyrosine phosphorylation and activation of ERK 1\/2 by Western blot analysis. The binding of flavonoids to TP in platelets, human myometrium and TP\u03b1\u2010 and TP\u03b2\u2010transfected HEK 293T cells was explored using binding assays and the TP antagonist<jats:sup>3<\/jats:sup>H\u2010SQ29548.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Apigenin, genistein, luteolin and quercetin impaired U46619\u2010induced calcium mobilization in a concentration\u2010dependent manner (IC<jats:sub>50<\/jats:sub>10\u201330\u2003\u00b5<jats:sc>m<\/jats:sc>). These flavonoids caused a significant impairment of U46619\u2010induced platelet tyrosine phosphorylation and of ERK 1\/2 activation. By contrast, in aspirin\u2010treated platelets all these flavonoids, except quercetin, displayed minor effects on thrombin\u2010induced calcium mobilization, ERK 1\/2 and total tyrosine phosphorylation. Finally, apigenin, genistein and luteolin inhibited by &gt;50%<jats:sup>3<\/jats:sup>H\u2010SQ29548 binding to different cell types.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>These data further suggest that flavonoids may inhibit platelet function by binding to TP and by subsequent abrogation of downstream signalling. Binding of these compounds to TP occurs in human myometrium and in TP\u2010transfected HEK 293T cells and suggests that antagonism of TP might mediate the effects of flavonoids in different tissues.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1365-2125.2007.02881.x","type":"journal-article","created":{"date-parts":[[2007,4,10]],"date-time":"2007-04-10T11:47:49Z","timestamp":1176205669000},"page":"133-144","source":"Crossref","is-referenced-by-count":78,"title":["Flavonoids inhibit the platelet TxA<sub>2<\/sub>signalling pathway and antagonize TxA<sub>2<\/sub>receptors (TP) in platelets and smooth muscle cells"],"prefix":"10.1111","volume":"64","author":[{"given":"Jos\u00e9 A.","family":"Guerrero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyre","family":"Navarro\u2010Nu\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda L.","family":"Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantino","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Vicente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Gibbins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,4,10]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01488.x"},{"key":"e_1_2_6_3_2","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0031-6997(24)01472-8","article-title":"The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer","volume":"52","author":"Middleton E","year":"2000","journal-title":"Pharmacol Rev"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.nutr.23.011702.073237"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2004.01.001"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.CRJ04003X"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrfmmm.2004.04.015"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/72.5.1150"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.103.23.2792"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1080\/09537100120111540"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1538-7836.2003.00294.x"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1538-7836.2003.00212.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1080\/10446670410001722140"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0163-7827(89)90002-7"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra052717"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01372.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.126.3_suppl.234S"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2005.10.001"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/349617a0"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)32161-0"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.5.2645"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2003.10.008"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2003.08.006"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI5116"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(84)90423-4"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1021\/jf040059f"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.plefa.2003.12.004"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(91)90208-E"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2004.11.019"},{"key":"e_1_2_6_30_2","first-page":"475","article-title":"Genistein, a protein tyrosine kinase inhibitor, inhibits thromboxane A2\u2010mediated human platelet responses","volume":"39","author":"Nakashima KT","year":"1991","journal-title":"Mol Pharmacol"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0952-3278(93)90118-G"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2004.01099.x"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1972.tb08800.x"},{"key":"e_1_2_6_34_2","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2144\/99262rr02","article-title":"Rapid measurement of intracellular calcium using a fluorescence plate reader","volume":"26","author":"Lin K","year":"1999","journal-title":"Biotechniques"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1006\/abbi.1998.0620"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(03)01430-3"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2005-863813"},{"key":"e_1_2_6_38_2","doi-asserted-by":"crossref","first-page":"317S","DOI":"10.1093\/ajcn\/81.1.317S","article-title":"Polyphenols and disease risk in epidemiologic studies","volume":"81","author":"Art ICW","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1080\/09537100500124442"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-200209000-00009"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)45614-1"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-1327.1999.00722.x"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(03)00069-8"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-05-1933"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M009218200"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-4165(98)00109-3"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-0760(00)00179-5"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-6980(01)00169-1"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1677\/joe.1.06466"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2125.2007.02881.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2125.2007.02881.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T17:40:21Z","timestamp":1736962821000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2125.2007.02881.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,10]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["10.1111\/j.1365-2125.2007.02881.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2125.2007.02881.x","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,10]]}}}